Identifying new drugs for the treatment of lung cancer
- Researcher: Dr Simona Polo
- Institution: IFOM The FIRC Institute of Molecular Oncology Foundation, Milan, Italy
- Award Amount: £228,551 for 3 years from 1st April 2019
- Cancer Type: Lung Cancer
Dr Simona Polo and her team based in Milan study a network of proteins, called the ubiquitin network, and the role it plays in cancer. They are particularly interested in a group of enzymes in the network called E3 ligases, which help cells to coordinate how they respond to different stimuli in a precise and selective manner.
In this project, Dr Polo’s team are investigating one of these enzymes, called NEDD4, which is overactive in some lung cancer cells and thought to contribute to the growth and division of cells. They aim to develop chemical inhibitors that block the NEDD4 enzyme from working, as well as furthering our understanding of how this enzyme is linked to cancer. The results of Dr Polo’s research will be the first steps towards a brand new targeted therapy for NSCLC.
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.